Three months of octreotide treatment decreases gastric acid secretion and argyrophil cell density in patients with Zollinger-Ellison syndrome and antral G-cell hyperfunction.

Autor: ANNIBALE, B., FAVE, G. DELLE, AZZONI, C., CORLETO, V., CAMBONI, G., D'AMBRA, G., PILATO, F. P., BORDI, C.
Zdroj: Alimentary Pharmacology & Therapeutics; Feb1994, Vol. 8 Issue 1, p95-104, 10p
Databáze: Complementary Index
Externí odkaz: